Actively Recruiting
Randomized Study Comparing MaioRegen Prime Implant to Standard Debridement Surgery for Knee Osteochondral Lesions
Led by Fin-Ceramica Faenza Spa · Updated on 2026-10-06
400
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of MaioRegen Prime compared to standard debridement surgery in patients with deep osteochondral lesions of the knee. This study involves patients with lesions of varying cause, size, shape, and location, and aims to assess outcomes through clinical, subjective, and objective measures. Participants are randomly assigned in a 21 ratio to receive either the MaioRegen Prime osteochondral scaffold implant or standard debridement surgery. All patients will have follow-up visits at 15 days, 6 weeks, 3, 6, 12, 18, and 24 months after surgery, with annual visits continuing until the last patient reaches 24 months. The study collects various clinical scores and MRI assessments to evaluate cartilage repair and knee function. During the study, participants will undergo evaluations including knee function questionnaires, pain scales, quality of life assessments, and MRI scans. Researchers will monitor clinical outcomes such as knee function scores, pain levels, cartilage repair quality, and any safety events or re-interventions. The total participation lasts at least 24 months, with continued annual follow-ups to track long-term outcomes.
CONDITIONS
Brief Title
MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
Research Team
S
Simal Trikam, Clinical Trial Manager
R
Roberta Miale, MEng
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here